The hepatitis diagnostic testing market is projected to grow from $3.26B in 2024 to $5.40B in 2033, led by universal screening and POC innovations.
Tech innovation and rising demand for accurate screening drive the hepatitis diagnostic testing market to $5.40B by 2033.